CD40LG and COVID-19: Although the frequency of Nucleoprotein- and Spike-specific IgM-ASCs were significantly higher than the unexposed subjects, it was not significantly different in the COVID-19 recovered patients (Count/106 PBMCs: Spike - 427±70, Nucleoprotein - 463±76) (Figure 3C).